Famotidine Tablets, USP 20 mg

Manufacturer
WOCKHARDT LIMITED
Effective date
2012-08-07
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:32:41

Label at a glance#

ProductFAMOTIDINE
Active ingredientFAMOTIDINE
Label structure10 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages

Dosage and administration

adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew. to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn do not use more than 2 tablets in 24 hours children under 12 years: ask a doctor

Storage and handling

read the directions and warnings before use store at 20°-25°C (68°-77°F) keep the carton. It contains important information. protect from moisture

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION


Drugs Facts

Active ingredient (in each tablets)

OTC - ACTIVE INGREDIENT SECTION

Famotidine USP 20 mg

Purpose

OTC - PURPOSE SECTION

Acid reducer

Uses

INDICATIONS & USAGE SECTION

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to famotidine or other acid reducers

OTC - DO NOT USE SECTION

Do not use
  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • if you have kidney disease, except under the advice and supervision of a doctor
  • with other acid reducers

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have
  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating, or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

OTC - STOP USE SECTION

Stop use and ask a doctor if
  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years and over:
  • to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew.
  • to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn
  • do not use more than 2 tablets in 24 hours
  • children under 12 years: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • read the directions and warnings before use
  • store at 20°-25°C (68°-77°F)
  • keep the carton. It contains important information.
  • protect from moisture

Inactive ingredients

INACTIVE INGREDIENT SECTION

Hydroxypropyl cellulose, hypromellose, microcrystalline cellulose, magnesium stearate, polyethylene glycol, pregelatinized starch, talc and titanium dioxide.

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-800-346-6854

Manufactured by:
Wockhardt Limited,
Mumbai, India.

Distributed by:
Wockhardt USA LLC.
20 Waterview Blvd.
Parsippany, NJ 07054
USA.

Iss.130810

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Famotidine 20 mg_OTC_500's Bottle Label
Famotidine 20 mg_OTC_500's Bottle Label

Famotidine 20 mg_OTC_500's Bottle Carton
Famotidine 20 mg_OTC_500's Bottle Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
310273famotidine 20 MG Oral TabletPSN2
310273famotidine 20 MG Oral TabletSCD2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
FAMOTIDINE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130364679374054GTIN-13: 0364679374054
EAN-13: 0364679374054
GTIN-12: 364679374054
UPC-A: 364679374054
GTIN storage (14 digits): 00364679374054
Famotidine 20 mg_OTC_500's Bottle Label.jpg, Famotidine 20 mg_OTC_500's Bottle Carton.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
396bde5c-c78e-2f8b-ab1f-2ee6ba32bcaeProduct name720260317
1e73f975-1ce7-705e-2bcf-788b1b5e24baProduct name520251124
cf645750-2e70-f6e1-c05a-a52847def5ddProduct name920250312
4fdc761c-585e-054b-8ebe-86130a26e4c1Product name220221205
fc2e1e31-353a-2c24-a4b4-fcf93bf7e38eProduct name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55648-374-00FAMOTIDINE38000 in 1 DRUMTABLET380002
55648-374-01FAMOTIDINE1 in 1 CARTONTABLET12
55648-374-01FAMOTIDINE30 in 1 BOTTLETABLET302
55648-374-05FAMOTIDINE1 in 1 CARTONTABLET12
55648-374-05FAMOTIDINE500 in 1 BOTTLETABLET5002
55648-374-07FAMOTIDINE10 in 1 CARTONTABLET102
55648-374-07FAMOTIDINE10 in 1 BLISTER PACKTABLET102
55648-374-08FAMOTIDINE1 in 1 CARTONTABLET12
55648-374-08FAMOTIDINE30 in 1 BOTTLETABLET302
55648-374-09FAMOTIDINE6500 in 1 DRUMTABLET65002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55648-374FAMOTIDINE TABLET [WOCKHARDT LIMITED]2Legacy NDC, 10 package rows20120807_fdff466f-9884-4bbd-89af-0e186a54801b.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
FAMOTIDINEACTIVE INGREDIENT5QZO15J2Z82
FAMOTIDINEACTIVE MOIETY5QZO15J2Z82
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTEDINACTIVE INGREDIENT2165RE0K142
HYPROMELLOSE 2910 (6 MPA.S)INACTIVE INGREDIENT0WZ8WG20P62
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I302
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQ2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJ2
TALCINACTIVE INGREDIENT7SEV7J4R1U2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55648-37455648-374-01, 55648-374-08, 55648-374-05, 55648-374-07, 55648-374-00, 55648-374-09

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 220 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / SUBLINGUAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL1576 mgExact identifier — unii candidate
28 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P6CAPSULE, EXTENDED RELEASE / ORAL232 mgExact identifier — unii candidate
16 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQSOLUTION / ORAL70200 mgExact identifier — unii candidate
36 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCREAM / TOPICAL80 mgExact identifier — unii candidate
40 equally ranked IID candidates
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTEDLOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE2165RE0K14TABLET / ORAL480 mgExact identifier — unii candidate
4 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJCAPSULE, DELAYED RELEASE / ORAL216 mgExact identifier — unii candidate
22 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, COATED / ORAL87 mgExact identifier — unii candidate
35 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQSPONGE / TOPICALNAExact identifier — unii candidate
36 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30IMPLANT / INTRAVITREALNAExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSOAP / TOPICAL1 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
TALCTALC7SEV7J4R1USUSPENSION / ORAL234 mgExact identifier — unii candidate
35 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQSOLUTION, CONCENTRATE / ORAL2813 mgExact identifier — unii candidate
36 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
39 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL21 mgExact identifier — unii candidate
22 equally ranked IID candidates
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTEDLOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE2165RE0K14CAPSULE / ORAL150 mgExact identifier — unii candidate
4 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJCAPSULE, COATED, EXTENDED RELEASE / ORAL19 mgExact identifier — unii candidate
22 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPINSERT, EXTENDED RELEASE / OPHTHALMIC0.4 mgExact identifier — unii candidate
40 equally ranked IID candidates
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTEDLOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE2165RE0K14TABLET, DELAYED RELEASE / ORAL103 mgExact identifier — unii candidate
4 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQLIQUID / TOPICAL1 %w/wExact identifier — unii candidate
36 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / SUBLINGUAL32.4 mgExact identifier — unii candidate
35 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJSUSPENSION/ DROPS / ORAL90 mgExact identifier — unii candidate
22 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJTABLET, EXTENDED RELEASE / ORAL184 mgExact identifier — unii candidate
22 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQGEL / TOPICAL6300 mgExact identifier — unii candidate
36 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE, COATED PELLETS / ORAL456 mgExact identifier — unii candidate
28 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPLOTION / TOPICALNAExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30GRANULE / ORAL629 mgExact identifier — unii candidate
39 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE, EXTENDED RELEASE / ORAL18 mgExact identifier — unii candidate
35 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQAEROSOL, POWDER / TOPICALNAExact identifier — unii candidate
36 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, EXTENDED RELEASE / ORAL173 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPPASTE, DENTIFRICE / DENTAL0.4 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SUSPENSION / ORAL64 mgExact identifier — unii candidate
39 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQOINTMENT / TOPICAL1950 mgExact identifier — unii candidate
36 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING / ORAL6 mgExact identifier — unii candidate
40 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQTABLET, ORALLY DISINTEGRATING / ORAL2 mgExact identifier — unii candidate
36 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER / ORAL25 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED, EXTENDED RELEASE / ORAL11 mgExact identifier — unii candidate
40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UGRANULE, FOR SUSPENSION / ORAL278 mgExact identifier — unii candidate
28 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, ORALLY DISINTEGRATING / ORAL1800 mgExact identifier — unii candidate
28 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / BUCCAL15 mgExact identifier — unii candidate
35 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UPOWDER, FOR SUSPENSION / ORAL4441 mgExact identifier — unii candidate
28 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE / ORAL2169 mgExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, FOR SUSPENSION / ORAL131 mgExact identifier — unii candidate
39 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQEMULSION / TOPICAL1.2 %w/wExact identifier — unii candidate
36 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SUSPENSION, EXTENDED RELEASE / ORAL71 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30RING / VAGINAL2 mgExact identifier — unii candidate
39 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P6TABLET, EXTENDED RELEASE / ORAL85 mgExact identifier — unii candidate
16 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE / ORAL729 mgExact identifier — unii candidate
35 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQSWAB / TOPICAL5250 mgExact identifier — unii candidate
36 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQSOLUTION/ DROPS / OPHTHALMIC1 %w/vExact identifier — unii candidate
36 equally ranked IID candidates
TALCTALC7SEV7J4R1UDROPS / ORALNAExact identifier — unii candidate
35 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UGRANULE, DELAYED RELEASE / ORAL789.6 mgExact identifier — unii candidate
28 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P6TABLET, COATED / ORAL12 mgExact identifier — unii candidate
16 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, DELAYED RELEASE / ORAL66 mgExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET / ORAL232 mgExact identifier — unii candidate
40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UIMPLANT / INTRAVITREAL1.66 mgExact identifier — unii candidate
28 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE, FOR SUSPENSION / ORAL296 mgExact identifier — unii candidate
35 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, EXTENDED RELEASE / ORAL5119 mgExact identifier — unii candidate
28 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A090837-001FAMOTIDINEFAMOTIDINE20MGTABLET / ORAL2010-08-04

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-0484e616aacf4f…
2026-08-18 06:07:402026-07A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-0431067a03dcf5…
2025-08-23 18:47 UTC2025-08A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-046a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-0403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-042680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-045bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-0479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-041e350fbaab3a…
2024-05-31 18:47 UTC2024-05A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-048072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-045c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-045d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-044b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-0474a2ff9319b5…
2022-03-09 01:35 UTC2022-03A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-0487673890dc5c…
2021-03-12 10:30 UTC2021-03A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-045aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-048869cabd3fbd…
2020-11-12 02:37 UTC2020-11A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04c0c555d07b60…
2019-12-14 00:12 UTC2019-12A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-043f01610625f2…
2019-09-15 20:21 UTC2019-09A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04b00525d2431f…
2019-07-19 19:46 UTC2019-07A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-046a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-041c564ffb4f44…
2023-12-20 04:57 UTC2023-12A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-049b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-043f0d92c62455…
2023-05-13 08:27 UTC2023-05A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04053a50430f4f…
2023-01-26 05:58 UTC2023-01A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-043bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-043a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A090837-001FAMOTIDINE20MGTABLET / ORAL2010-08-04f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d0e9c888-c641-40a8-9338-d83b6de02385fdff466f-9884-4bbd-89af-0e186a54801b2012-08-07WarningsExact identifier
spl id: d0e9c888-c641-40a8-9338-d83b6de02385
spl set id: fdff466f-9884-4bbd-89af-0e186a54801b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.